Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality.
Carolin SiechMario de AngelisLetizia Maria Ippolita JannelloFrancesco Di BelloNatali Rodriguez PeñarandaJordan A GoyalZhe TianFred SaadShahrokh F ShariatStefano PuliattiNicola LongoOttavio de CobelliAlberto BrigantiBenedikt HoehPhilipp MandelLuis A KluthFelix K H ChunPierre I KarakiewiczPublished in: Prostate cancer and prostatic diseases (2024)
Compared to acinar adenocarcinoma, patients with neuroendocrine carcinoma of all stages and locally advanced ductal carcinoma exhibit higher CSM rates. Conversely, CSM rates of mucinous and signet ring cell adenocarcinoma do not differ from those of acinar adenocarcinoma.
Keyphrases
- locally advanced
- squamous cell carcinoma
- prostate cancer
- rectal cancer
- neoadjuvant chemotherapy
- radiation therapy
- phase ii study
- papillary thyroid
- type iii
- single cell
- radical prostatectomy
- low grade
- cardiovascular events
- risk factors
- squamous cell
- lymph node metastasis
- type diabetes
- stem cells
- bone marrow
- young adults
- clinical trial
- double blind
- childhood cancer